小型高密度脂蛋白颗粒血浆水平与成人糖尿病患者冠状动脉粥样硬化进展相关
基于ELSA-Brasil队列4331名参与者,2型糖尿病患者的冠状动脉钙化发生/进展率高于非糖尿病者;在461名未使用他汀且无基线动脉粥样硬化性心血管疾病的2型糖尿病亚组中,HDLp1第三分位者CAC发生/进展风险较第一分位高140%(95%CI 32%-341%,P<.001),HDLp1纳入显著改善风险分类(NRI 13.6%,95%CI 2.8%-18.8%,P=.004)。
要点
- 2型糖尿病患者冠状动脉钙化发生/进展率高于非糖尿病参与者。
- 在461名未用他汀的2型糖尿病亚组中,143名(31.0%)出现CAC发生/进展。
- HDLp1第三分位者CAC发生/进展可能性较第一分位高140%(95%CI 32%-341%,P<.001)。
核心结论
- HDLp1浓度与2型糖尿病患者的CAC发生/进展显著相关,可能改善该人群冠状动脉粥样硬化进展的风险区分。
研究设计与样本
- 分析ELSA-Brasil队列4331名参与者,比较伴与不伴2型糖尿病者的CAC发生/进展。
- 进一步评估461名未使用他汀、无基线ASCVD的2型糖尿病亚组中HDLp1(<8 nm)与CAC结局的关联。
主要发现
- 2型糖尿病患者的CAC发生/进展率高于非糖尿病参与者。
- 461名未用他汀的2型糖尿病亚组中,143名(31.0%)出现CAC发生/进展。
- HDLp1第三分位者CAC发生/进展可能性较第一分位高140%(95%CI 32%-341%,P<.001)。
- 纳入HDLp1显著改善CAC风险分类,NRI为13.6%(95%CI 2.8%-18.8%,P=.004)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Type 2 diabetes mellitus (T2DM) is a major driver of coronary atherosclerosis progression, yet its impact is highly heterogeneous. Insulin resistance contributes to a complex interplay of metabolic disturbances that accelerate atherogenesis to varying degrees. Identifying biomarkers that refine cardiovascular risk prediction in this population remains a clinical priority. OBJECTIVE: To evaluate the association between small high-density lipoprotein (HDL) particle concentration and the incidence/progression of coronary artery calcium (CAC) in individuals with T2DM. METHODS: We analyzed 4331 participants from the ELSA-Brasil cohort. CAC incidence/progression was compared between individuals with and without T2DM. A subgroup of 461 non-statin users with T2DM and no baseline atherosclerotic cardiovascular disease (ASCVD) was further assessed for associations between small HDL particles (<8 nm, HDLp1) and CAC outcomes. RESULTS: Individuals with T2DM showed increased CAC incidence/progression rates compared to nondiabetic participants. Among 461 non-statin users with T2DM, 143 (31.0%) experienced CAC incidence/progression. Higher plasma concentrations of HDLp1 (third tertile) were associated with a 140% (95% CI, 32%-341%; P < .001) greater likelihood of CAC incidence/progression compared to the first tertile. The inclusion of HDLp1 significantly improved CAC risk classification, with a net reclassification improvement (NRI) of 13.6% (95% CI, 2.8%-18.8%; P = .004). CONCLUSION: HDLp1 concentration is significantly associated with CAC incidence/progression in individuals with T2DM and may improve risk discrimination for coronary atherosclerosis progression in this population.
引用
- Teles BSBS, Ramalho SHR, Bittencourt MS, et al. Plasma Levels of Small HDL Particles Are Associated With Coronary Atherosclerosis Progression in Adults With Diabetes. J Clin Endocrinol Metab. 2025. PMID: 40177741. doi:10.1210/clinem/dgaf215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。